COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Contrast Sensitivity in Glaucoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00947869
Recruitment Status : Unknown
Verified July 2009 by University of Erlangen-Nürnberg Medical School.
Recruitment status was:  Recruiting
First Posted : July 28, 2009
Last Update Posted : July 28, 2009
Information provided by:
University of Erlangen-Nürnberg Medical School

Brief Summary:
The primary aim of the Erlangen´s Glaucoma Contrast Sensitivity-Study (EGCS-Study) is the evaluation of the diagnostic and prognostic validity of a diagnostic procedure, measuring contrast sensitivity. No therapeutic studies are performed.

Condition or disease
Primary Open Angle Glaucoma Secondary Open Angle Glaucoma Due to PEX

Layout table for study information
Study Type : Observational
Estimated Enrollment : 30 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Glaucoma Including Pseudoexfoliation Syndrome (SFB 539)
Study Start Date : April 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Glaucoma

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
primary care clinic
  • Patients: Primary open angle glaucoma, secondary open angle glaucoma due to PEX
  • Healthy volunteers (for reliability analysis)

Inclusion Criteria:

  • Age > 18
  • Best corrected visual acuity 0.8 or better
  • European

Exclusion Criteria:

  • eye diseases: Infantile glaucoma, angle glaucoma, secondary open angle glaucoma, wich are not due to PEX, diseases involving retina, condition after ophthalmological operations or trauma, cataract, diseases concerning the refractive system, age-related macular degeneration, diabetic retinopathy, optic neuropathy (MS, neuritis), amblyopia
  • Any neurological diseases
  • Systemic diseases with potentially ocular involvement (e.g., diabetes mellitus)
  • Systemic drugs with potentially ocular involvement
  • ocular drugs

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00947869

Layout table for location contacts
Contact: Anselm G Juenemann, Prof.

Layout table for location information
University Eye Hospital Recruiting
Erlangen, Bavaria, Germany, 91054
Contact: Hohberger    **49-9131-8534521      
Sponsors and Collaborators
University of Erlangen-Nürnberg
Layout table for investigator information
Study Chair: Anselm G Juenemann, Prof. University Erlangen-Nuremberg
Layout table for additonal information
Responsible Party: University Eye Hospital Erlangen, University of Erlangen-Nürnberg Identifier: NCT00947869    
Other Study ID Numbers: DFG-SFB539-H
First Posted: July 28, 2009    Key Record Dates
Last Update Posted: July 28, 2009
Last Verified: July 2009
Additional relevant MeSH terms:
Layout table for MeSH terms
Glaucoma, Open-Angle
Ocular Hypertension
Eye Diseases